The organization highlighted a dangerous lack of distinction between clinically validated medical devices and general wellness tools that estimate high-stakes physiologic parameters like oxygen saturation and electrocardiograms.
While the FDA has issued guidance on Clinical Decision Support (CDS) tools, ECRI argues that enforceable transparency requirements are missing.
Proposed legislative exemptions for certain CDS tools could further reduce oversight, potentially leaving clinicians in the dark about how recommendations are generated.
To protect patients in this rapidly evolving landscape, ECRI urged Congress to adopt four critical pillars of oversight:
- Clear Classification: Implement a public-facing system to clearly identify validated medical products.
- Expanded Authority: Update oversight to account for the risks of inaccurate physiologic data, rather than just traditional physical or electrical hazards.
- Enforceable Standards: Require total transparency for all CDS tools used in direct clinical care.
- Demographic Validation: Mandate that devices be proven accurate across diverse patient populations to advance health equity.